Document is current
Any future updates will be listed below
-
Authors
Ng, Fiona FJ
Verma, Rashmi
Sani, Levana
Irwanto, Astrid
Lee, Michael
Wee, Angeline
Chng, Shih Kiat
Wong, Melvyn
Chan, Alexandre
-
Funding
Funding for this research was provided by:
NalaGenetics Pte Ltd
- License Information
-
More Information
Article History
Received: 7 August 2024
Revised: 11 February 2025
Accepted: 3 March 2025
First Online: 12 March 2025
Ethics approval and consent to participate
: This study was approved by Raffles Hospital Institutional Review Board under reference number 2017/007. All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone outside the research group so cannot be used to identify individuals.
: Nalagenetics Pte Ltd, Singapore, is the provider of the multi-gene panel testing conducted for this study. Author FN, RV, AI and LS were employed by NalaGenetics Pte Ltd, Singapore. Author AC is a scientific advisor for Nalagenetics Pte Ltd, Singapore. AI and LS have financial holdings in Nalagenetics Pte Ltd, Singapore.
